One size does not fit all: Evaluating disparities in lung cancer screening eligibility amongst the Hispanic population by Coral Olazagasti, Matthew Ehrlich, Nagashree Seetharamu

Get full text

Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits by Coral Olazagasti MD, Nagashree Seetharamu MD

Get full text

Optimizing Tissue Use: A Step-wise Approach to Diagnosing Squamous Cell Lung Carcinoma on Small Biopsies by Coral Olazagasti, Isabel Preeshagul, Mohamed Aziz, Nagashree Seetharamu

Get full text

Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics by Karie Runcie, Daniel R. Budman, Veena John, Nagashree Seetharamu

Get full text

1430 Development of ICTIS: a novel scoring system for the inclusivity of advanced non-small-cell lung cancer immunotherapy clinical trials by Nagashree Seetharamu, Kira Nguyen, Ashley Wei, Wint Yan Aung

Impact of Family and Social Network on Tobacco Cessation Amongst Cancer Patients by Melissa Neumann MD, Neal Murphy MD, Nagashree Seetharamu MD

Get full text

Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer by Kevin Y Wang, James Newman, Chung-Shien Lee, Nagashree Seetharamu

Get full text

1429 Application of ICTIS to currently recruiting clinical trials: a novel scoring system to assess the inclusivity of advanced non-small-cell lung cancer immunotherapy trials by Nagashree Seetharamu, Kira Nguyen, Ashley Wei, Wint Yan Aung, Nicole Spinelli

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications by Eziafa I. Oduah, Eziafa I. Oduah, Eziafa I. Oduah, Susan T. Sharfstein, Nagashree Seetharamu, Steven R. Grossman, Larisa Litovchick

Get full text

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon’s two-stage trial by Nagashree Seetharamu, Diana Martins-Welch, Nina Kohn, Joseph Herman, Daniel Koffler, Jacob Eckstein, Maged Ghaly, Louis Potters, Douglas Frank, Kevin Sullivan, Bhupesh Parashar

Get full text

676 Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in phase 1b/2 study for first-line treatment of R/M H... by Elizabeth Evans, Nagashree Seetharamu, Crystal Mallow, Maurice Zauderer, Barbara Burtness, Marya Chaney, Alexander Spira, Conor Steuer, Tarek Mekhail, J Thaddeus Beck, Douglas Adkins, Terrence Fisher, Amber Foster, John Leonard, Nabil F Saba, Megan Baumgart, Steven Hager, Christopher Chay